VYMAB Insider Trading Activity and SEC Form 4 Filings
VYMAB insider trading summary
No open-market insider purchases or sales of Y-mAbs Therapeutics, Inc. (VYMAB) have been reported on SEC Form 4 in the past 12 months.
Latest VYMAB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 14, 2020 | Thomas Gad | See Remarks | Sell | $212K (4,000 @ $52.89) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.